Cardiovascular Journal of Africa: Vol 29 No 3 (May/Junel 2018)

2 / 76

DYNA INDAPAMIDE SR. Each tablet contains 1,5 mg indapamide. S3 A42/7.1/0790. NAM NS2 12/7.1/0138. For full prescribing information, refer to the professional information approved by SAHPRA, 25 November 2011.
1) Weidmann P. Metabolic profile of indapamide sustained-release in patients with hypertension. Drug Safety 2001;24(15):1155-1165. 2) Database of Medicine Prices (11 April 2018). Department of Health website.http://
- Accessed on 11 April 2018. DINF477/06/2018.
For further product information contact PHARMA DYNAMICS P O Box 30958 Tokai Cape Town 7966 Fax +27 21 701 5898
Email CUSTOMER CARE LINE 0860 PHARMA (742 762) / +27 21 707 7000
SUSTAINED RELEASE
METABOLICALLY NEUTRAL 1
only generic 1,5 mg
sustained release
formulation
R37,162